Thirty Days of Release, One Needle to Pass
TL;DR for operators Developing a monthly injectable medicine requires more than slowing drug release. The formulation must also pass through a needle, form a stable depot, and release its active ingredient at an acceptable rate. In an industrial study, Bannigan and colleagues1 combined automated experimentation with AI-guided optimization to evaluate 181 formulations over approximately 15 weeks, identifying four leads with acceptable reported administration properties and differentiated 30-day in vitro release profiles. ...